China Isotope & Radiation Corporation
1763.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.01B
Close$
Share Statistics
| Market cap | $4.01 Billion |
|---|---|
| Enterprise Value | $4.53 Billion |
| Dividend Yield | $0.35 (3.71%) |
| Earnings per Share | $1 |
| Beta | 0.51 |
| Outstanding Shares | 319,843,635 |
Return
| Return on Equity | 13.75% |
|---|---|
| Return on Assets | 4.54% |
| Return on Invested Capital | 18.98% |
Valuation & Multiples
| P/E Ratio | 11.11 |
|---|---|
| PEG | -147.01 |
| Price to Sales | 0.28 |
| Price to Book Ratio | 0.49 |
| Enterprise Value to Revenue | 0.31 |
| Enterprise Value to EBIT | 2.22 |
| Enterprise Value to Net Income | 6 |
| Total Debt to Enterprise | 0.68 |
| Debt to Equity | 0.58 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 28, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
March 31, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About China Isotope & Radiation Corporation
3,655 employees
CEO: Junqi Zhang China Isotope & Radiation Corporation is dedicated to the development, production, and distribution of diagnostic and therapeutic radiopharmaceuticals, as well as radioactive source products for both medical and industrial applications t...